Have We Entered A Stealth Bear Market?
Embecta Corp EMBC
$3.64
▼ -0.55%
($-0.02)
💰 High Dividend
🗓️ Earnings Next Week
Open
$3.61
Prev Close
$3.66
Day Range
$3.53 – $3.69
52W Range
$2.77 – $15.55
Market Cap
$215.95M
P/E (TTM)
1.93
Beta
0.83
Div Yield
1.09%
EPS (TTM)
$1.90
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-03-21 |
| Shares Out. | 59,330,000 |
| Website | embecta.com/ ↗ |
| Phone | 13026587581 |
| Employees | 1,850 |
| Revenue | $221.8M |
| Gross Profit | $127.8M |
| Net Income | -$4.1M |
| Free Cash Flow | $204.7M |
| Total Assets | $1.03B |
| Total Liabilities | $1.66B |
| Equity | -$626.1M |
About Embecta Corp
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Embecta Corp is a publicly traded company under the ticker symbol EMBC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)